Evidence map›Paper›PMID 42346163›Full record

ArticleEpidemiologia (Basel, Switzerland)2026

Machine Learning for Coronary Heart Disease Prediction: Comparative Analysis of Framingham and Cleveland Subset of the UCI Dataset with SHAP-Based Interpretability.

Shreyas Raman, Devansh Thakkar, Jacques Calixte, Rahul Kumar, Kyle Sporn, Kiran Marla, Divyam Goel, Rhea Gopali, Nitin Chetla, Saif Pasha and 3 more

Abstract read
In one paragraph

Article in Epidemiologia (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shreyas RamanKhoury College of Computer Sciences, Northeastern University, Boston, MA 02115, USA.
Devansh ThakkarKhoury College of Computer Sciences, Northeastern University, Boston, MA 02115, USA.
Jacques CalixteVagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.ORCID 0009-0005-1654-8913
Rahul KumarDepartment of Medicine, University of Massachusetts Chan School of Medicine, Worcester, MA 01655, USA.ORCID 0000-0001-8574-2895
Kyle SpornDepartment of Medicine, Norton College of Medicine, SUNY Upstate Medical University, Syracuse, NY 13210, USA.ORCID 0009-0005-5707-9009
Kiran MarlaCarver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.ORCID 0000-0001-9513-1422
Divyam GoelDepartment of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.ORCID 0000-0002-5281-4255
Rhea GopaliSchool of Osteopathic Medicine, Campbell University School of Osteopathic Medicine, Lillington, NC 27546, USA.
Nitin ChetlaDepartment of Radiology, University of Virginia, Charlottesville, VA 22903, USA.ORCID 0009-0003-3496-262X
Saif PashaDepartment of Medicine, Virginia Tech Carilion School of Medicine, Roanoke, VA 24016, USA.
Nikitha RavisankarDepartment of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA.ORCID 0000-0002-8130-1619
Ryung LeeDepartment of Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14203, USA.
Ciprian IonitaDepartment of Medicine, UB Clinical and Translational Research Center, University at Buffalo, Buffalo, NY 14203, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCardiovascular disease (CVD) remains the leading cause of mortality worldwide, with coronary artery disease (CAD), also known as ischemic heart disease (IHD), responsible for approximately 13% of global deaths in 2021. Studies applying machine learning (ML) and deep learning (DL) to heart disease classification have demonstrated promising results in risk prediction and feature extraction. BACKGROUND/

objectivesIn this study, we develop an AI/ML framework to predict and classify ischemic heart disease risk using publicly available datasets, the Framingham Heart Study and the Cleveland subset of the UCI Heart Disease dataset, along with explanations for how predictions were made by a process called SHAP (SHapley Additive exPlanations).

methodsWe implemented a leakage-controlled machine learning pipeline that included data cleaning, stratified 80/20 train-test splitting, training-fold-only feature scaling and class balancing, 5-fold hyperparameter tuning, SHAP interpretability, and Brier score-based calibration assessment. Logistic regression, random forest, K-nearest neighbors, XGBoost, and a feedforward neural network were evaluated on the Framingham dataset and the Cleveland subset of the UCI Heart Disease dataset. Performance was assessed using accuracy, precision, recall, F1-score, Matthews correlation coefficient, AUROC, and Brier score.

resultsAfter leakage-controlled evaluation, Framingham performance was more modest than in the preliminary analysis. Logistic regression achieved the highest AUROC on the Framingham dataset (0.7234), while random forest achieved the lowest Brier score (0.1750), and the feedforward neural network achieved the highest accuracy (0.7719). On the Cleveland subset, logistic regression achieved the strongest threshold-based performance (accuracy 0.8667, precision 0.8571, recall 0.8571, F1-score 0.8571, MCC 0.7321), whereas K-nearest neighbors achieved the highest AUROC (0.9531) and lowest Brier score (0.0942). SHAP highlighted systolic blood pressure, smoking status, and hypertension as influential predictors (Framingham) and number of major vessels, chest pain type, thallium stress-test result (thal; normal, fixed defect, or reversible defect), and age (Cleveland) as top predictors.

conclusionsOptimal model performance is dataset-dependent, and SHAP enhances clinical interpretability. Broader access to high-quality, de-identified medical data could accelerate reproducible ML research in cardiology.

Indexed as

cardiovascular risk predictionCleveland subsetcoronary heart diseaseFramingham Heart Studyinterpretabilitymachine learningSHAP

Identifiers

PMID42346163
PMCPMC13298444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.